Comparison
Aars1 Related Leukoencephalopathy Cn379160 vs 17q24 2 Microdeletion Syndrome C5680185
Clinical comparison between Aars1 Related Leukoencephalopathy CN379160 and 17q24 2 Microdeletion Syndrome for differential diagnosis and treatment planning.
Aars1 Related Leukoencephalopathy Cn379160
A rare genetic condition affecting the brain's white matter, caused by mutations in the AARS1 gene. It can cause movement problems, developmental delays, and other neurological symptoms.
17q24 2 Microdeletion Syndrome C5680185
A rare genetic disorder caused by deletion of genetic material on chromosome 17. Individuals may have developmental delays, facial features, and other medical issues. Care is supportive and multidisciplinary.
6 comparison axes
Onset
Aars1 Related Leukoencephalopathy Cn379160
0-60
17q24 2 Microdeletion Syndrome C5680185
0-null
Onset patterns differ
Severity
Aars1 Related Leukoencephalopathy Cn379160
severe
17q24 2 Microdeletion Syndrome C5680185
moderate
Different severity levels
Chronic
Aars1 Related Leukoencephalopathy Cn379160
Chronic
17q24 2 Microdeletion Syndrome C5680185
Chronic
Differing course
Communicable
Aars1 Related Leukoencephalopathy Cn379160
No
17q24 2 Microdeletion Syndrome C5680185
No
Different transmission
Body System
Aars1 Related Leukoencephalopathy Cn379160
neurologic
17q24 2 Microdeletion Syndrome C5680185
congenital
Same/different system
Category
Aars1 Related Leukoencephalopathy Cn379160
neurologic
17q24 2 Microdeletion Syndrome C5680185
genetic
Different category
Bottom line
aars1-related-leukoencephalopathy-CN379160 and 17q24-2-microdeletion-syndrome-C5680185 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Aars1 Related Leukoencephalopathy Cn379160 | 17q24 2 Microdeletion Syndrome C5680185 | Discriminating power |
|---|---|---|---|
| Developmental delay | May accompany white-matter–related neurologic disease. | May occur with congenital or facial features. | Moderate |
| Movement problems | Described as a possible neurologic feature. | Not specifically established in the supplied description. | Moderate |
| Congenital features | Not established from the supplied source. | Facial features and other medical issues may occur. | Moderate |
When to favor each condition
Choose Aars1 Related Leukoencephalopathy Cn379160 when
Prominent white-matter neurologic phenotype
The condition is framed as an AARS1-related leukoencephalopathy.
Moderate
Clinically correlated AARS1 variant
A gene-specific finding favors this diagnosis over a chromosomal deletion.
High
Severe neurologic course without deletion evidence
Supplied severity is severe, but the course needs clinical interpretation.
Low
Choose 17q24 2 Microdeletion Syndrome C5680185 when
Confirmed 17q24.2 microdeletion
The syndrome is defined by deletion of material in this region.
High
Congenital and developmental features predominate
The source emphasizes developmental delay, facial features, and other issues.
Moderate
Supportive multidisciplinary care is central
Care is described as supportive rather than disease-specific.
Moderate
How key tests differ
| Test | Aars1 Related Leukoencephalopathy Cn379160 | 17q24 2 Microdeletion Syndrome C5680185 | Interpretation |
|---|---|---|---|
| AARS1 sequencing | A pathogenic or likely pathogenic variant may support diagnosis. | Not expected to define the deletion syndrome. | Requires clinical correlation; it does not exclude another genetic condition. |
| Chromosomal microarray | Not the primary test for an AARS1 sequence variant. | May detect a 17q24.2 microdeletion. | Deletion size and involved genes need specialist review. |
| Brain MRI | White-matter abnormality may be relevant; pattern is unspecified. | No specific imaging finding is established here. | Imaging aids evaluation but does not alone diagnose either condition. |
Prognosis comparison
Aars1 Related Leukoencephalopathy Cn379160
- Outcome
- Potentially severe chronic neurologic condition; individual outcome is not established.
- Factors
- Variant effect, neurologic findings, and developmental support.
17q24 2 Microdeletion Syndrome C5680185
- Outcome
- Framed as a moderate chronic congenital condition; outcome varies.
- Factors
- Deletion extent, associated issues, and supportive care.
Time frame: A lifelong course is possible; precise milestones are not established.
Diagnostic confirmation, comorbidities, therapies, and family context.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic impairment | Movement problems and other neurologic symptoms may occur. Specific neurologic complications are not established. Severity and progression are not quantified in the source. |
| Developmental disability | Developmental delay is described. Developmental delay is also described. Functional impact varies and requires individual assessment. |
| Other medical issues | Issues beyond neurologic disease are not established here. Other medical issues may occur. Screening should be directed by a clinician. |
Patient education highlights
- HighGenetic confirmation
Symptoms alone do not establish either diagnosis; results need specialist interpretation.
- HighCare planning
Both may need long-term developmental follow-up; deletion-syndrome care is supportive and multidisciplinary.
- MediumUncertainty
Exact onset, complications, and outcomes are not established by these source data.